NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders

CLEVELAND, OH / ACCESSWIRE / March 1, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today provided an update on business developments, financing and the 2024 annual meeting.

The previously disclosed $10.7 million financing transaction with Sumner Global LLC remains pending, as Sumner Global has not yet obtained the funding necessary to close the transaction. To provide interim working capital, the Company's primary creditor AJB Capital Investments, LLC and another funding source have entered into separate borrowing arrangements with NovAccess Global. Details of these transactions have been filed under Form 8-K with the Securities and Exchange Commission (SEC) on February 28^th, 2024.

NovAccess Global filed its fiscal 2023 annual report on Form 10-K with the SEC on February 15, 2024 and its financial results for the first quarter of fiscal 2024 on Form 10-Q on February 27, 2024.

The Company is hosting a Virtual Annual Meeting of Shareholder on Wednesday, May 6^th, 2024 at 12:00 p.m. Eastern Time. Shareholders of record as of April 1^st, 2024 will be able to vote and ask questions online during the meeting. If you would like to attend the virtual meeting and have your control number, please log in 15 minutes prior to the start of the meeting using the link to be made available on investor relations/presentations section of the Company's website. Shareholders will not be able to attend in person and are encouraged to vote their shares prior to the annual meeting.

The Company also announced that Dr. Dwain K. Irvin, NovAccess Global's Chief Executive Officer, and Dr. Christopher Wheeler, Ph.D., President, StemVax Therapeutics Inc., a division of NovAccess Global, will be presenting at the World Brain Mapping Foundation (WBMF) Annual World Congress, to be held on March 14-17, 2024, in Los Angeles, CA. For additional information on the event, please visit https://www.worldbrainmapping.org/annual-congress/.

The World Brain Mapping Foundation's Annual Congress event is designed to recognize pioneers in brain mapping, health policy, neuroscience, and mental health philanthropy, amongst others, while connecting to its mission and bringing its message of neurotech innovation and innovation to the masses. The event also recognizes students, young investigators, and leaders in the field of brain mapping and therapeutics who have made significant contributions as trailblazers. Gala participants include major philanthropists, celebrities, NHL/NBA/MLS/NHF, leading scientists, physicians, neurosurgeons, and neurotechnology.